Melatonin study
This article was originally published in The Tan Sheet
Executive Summary
"There is no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restrictions, such as jet lag and shift work disorder," a meta-analysis published in the British Medical Journal Feb. 18 finds. Nina Buscemi, University of Alberta, et al., analyzed 34 studies dated from 1999 to 2003 to rate the efficacy and safety of melatonin. Six trials with 97 participants showed no evidence that melatonin affects sleep onset latency in people with secondary sleep disorders. Nine trials with 427 patients showed no evidence that melatonin had an effect on sleep onset latency in people who had sleep disorders accompanying sleep restriction, and 17 trials with 651 participants showed no evidence of adverse effects in short term use of three months or less, Buscemi et al. report...
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.